DEGLI UBERTI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 28.722
AS - Asia 13.729
EU - Europa 9.890
SA - Sud America 2.383
AF - Africa 236
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 19
Totale 54.999
Nazione #
US - Stati Uniti d'America 28.204
SG - Singapore 5.434
CN - Cina 4.387
DE - Germania 3.087
BR - Brasile 2.049
UA - Ucraina 1.991
HK - Hong Kong 1.336
TR - Turchia 1.177
IT - Italia 1.103
GB - Regno Unito 912
RU - Federazione Russa 733
FI - Finlandia 716
VN - Vietnam 663
SE - Svezia 525
MX - Messico 252
PL - Polonia 246
CA - Canada 211
FR - Francia 189
IN - India 154
AR - Argentina 141
ZA - Sudafrica 117
BD - Bangladesh 94
JP - Giappone 88
ID - Indonesia 84
BE - Belgio 71
NL - Olanda 70
ES - Italia 68
IQ - Iraq 54
EC - Ecuador 53
PK - Pakistan 41
LT - Lituania 37
AT - Austria 32
MA - Marocco 31
VE - Venezuela 30
PY - Paraguay 28
UZ - Uzbekistan 28
CO - Colombia 27
IR - Iran 26
CL - Cile 19
KE - Kenya 19
TN - Tunisia 18
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
AU - Australia 15
CZ - Repubblica Ceca 15
IE - Irlanda 15
EU - Europa 14
NP - Nepal 14
UY - Uruguay 14
EG - Egitto 12
IL - Israele 12
PE - Perù 12
RO - Romania 12
DO - Repubblica Dominicana 10
DZ - Algeria 10
MY - Malesia 10
TT - Trinidad e Tobago 10
AZ - Azerbaigian 9
JO - Giordania 9
LB - Libano 9
BG - Bulgaria 8
BO - Bolivia 8
DK - Danimarca 8
CH - Svizzera 7
JM - Giamaica 7
KG - Kirghizistan 7
KZ - Kazakistan 7
AL - Albania 6
AM - Armenia 6
PS - Palestinian Territory 6
PT - Portogallo 6
GA - Gabon 5
HN - Honduras 5
MD - Moldavia 5
OM - Oman 5
PA - Panama 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CR - Costa Rica 4
GT - Guatemala 4
HU - Ungheria 4
RS - Serbia 4
TH - Thailandia 4
BH - Bahrain 3
BY - Bielorussia 3
CY - Cipro 3
ET - Etiopia 3
GE - Georgia 3
KR - Corea 3
KW - Kuwait 3
LV - Lettonia 3
ML - Mali 3
NG - Nigeria 3
NI - Nicaragua 3
QA - Qatar 3
SN - Senegal 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BF - Burkina Faso 2
Totale 54.959
Città #
Singapore 3.139
Woodbridge 3.027
Ashburn 2.779
Fairfield 2.449
Jacksonville 2.160
Chandler 2.078
Houston 1.753
Beijing 1.417
Santa Clara 1.381
Hong Kong 1.331
Ann Arbor 1.271
Seattle 964
Wilmington 951
Cambridge 747
Izmir 677
Nanjing 619
Los Angeles 447
Princeton 440
Dallas 412
Munich 399
Addison 384
New York 351
San Diego 277
Boardman 269
Warsaw 237
Ho Chi Minh City 236
Milan 229
São Paulo 210
Shanghai 200
Shenyang 198
Helsinki 180
Nanchang 180
Mexico City 178
Dearborn 163
Hanoi 141
Turku 137
Ferrara 135
Hebei 134
Tianjin 129
Hefei 127
Changsha 117
Washington 112
Bremen 109
Buffalo 100
London 99
Jiaxing 97
Brooklyn 87
Jinan 84
Tokyo 81
Denver 77
Chicago 76
Montreal 75
Falls Church 69
Mountain View 67
Johannesburg 66
San Francisco 65
Brussels 64
Orem 64
Boston 63
Moscow 62
San Mateo 62
Belo Horizonte 57
Phoenix 57
Rio de Janeiro 53
Stockholm 53
Chennai 52
Poplar 52
Toronto 52
Atlanta 49
Kunming 49
Guangzhou 48
Norwalk 48
Zhengzhou 47
Falkenstein 45
Frankfurt am Main 45
Ningbo 45
Redwood City 45
The Dalles 45
Carrara 40
Auburn Hills 36
Tappahannock 36
Ankara 34
Brasília 34
Manchester 34
Nuremberg 34
Rome 34
Taizhou 34
Augusta 33
Jakarta 32
Leawood 30
Porto Alegre 30
Charlotte 28
Düsseldorf 28
Haiphong 28
Orange 28
Campinas 27
Council Bluffs 27
Des Moines 27
Curitiba 26
Hải Dương 26
Totale 35.760
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 394
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 282
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 237
ROLL technique application for Minimally-Invasive Radioguided Parathyroidectomy (MIRP) in Hyperparathyroidism (HPT) 235
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 230
Igf-I influences everolimus activity in medullary thyroid carcinoma 223
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 221
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 217
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 216
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 213
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 211
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 210
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 209
Characterization of a deleted Y chromosome in a male with Turner stigmata 207
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 206
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 205
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 204
Circadian profile of plasma calcitonin gene-related peptide in healthy man 200
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 200
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 199
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 199
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 199
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 196
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 195
A c-myc gene variant without exon 1 and with an abnormal methylation pattern inherited in a woman with no evidence of malignancy 193
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 193
Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids 193
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 192
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 191
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 191
A practical method for the estimation of therapeutic activity in the treatment of Graves' hyperthyroidism 191
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 189
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 188
Dermorphin inhibits spinal nociceptive flexion reflex in humans 187
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 184
Functional characterization of a new deletion in CDKN1B 5'-UTR region 184
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 184
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 184
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 181
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 181
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 181
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 180
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 179
Evidence for androgen receptor gene expression in human thyroid cells and tumours 179
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 179
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 178
Evaluation of ''ROLL-like'' procedure for minimallyinvasive radioguided parathyroidectomy (MIRP) in hyperparathyroidism (HPT). 176
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 175
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 175
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 175
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 175
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 174
c-myc oncogene alterations in human thyroid carcinomas. 174
Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide 174
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 173
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 173
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 172
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 172
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 172
Growth hormone excess promotes breast cancer chemoresistance 171
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 171
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 170
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 170
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 169
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 169
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 168
Antiproliferative effects of somatostatin analogs in pituitary adenomas 168
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 168
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 168
Growth hormone induces chemoresistance in breast cancer cells 168
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 168
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 168
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 167
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 166
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 166
Detection of androgen receptor (AR) mRNA by the reverse transcription polymerase chain reaction (RT-PCR) in human thyroids. 165
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 165
Diurnal rhythm of plasma catecholamines in acromegaly 165
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 165
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 164
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 164
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 164
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 163
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 163
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 162
Circadian variations of plasma TSH in patients with severe hypothyroidism 162
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 162
Atrial strain is the main determinant of release of atrial natriuretic peptide 161
miR-15a and miR-16-1 down-regulation in pituitary adenomas 161
Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach 161
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide 160
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 160
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 160
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 160
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 159
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 159
Effect of bromocriptine on the control of plasma aldosterone diurnal variation in normal supine man 159
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids 159
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 158
Pituitary side effects of old and new drugs. 158
Totale 18.384
Categoria #
all - tutte 250.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 16.609
Totale 266.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.618 0 0 0 0 0 495 115 520 68 522 688 210
2021/20224.080 129 416 246 180 192 186 164 183 164 338 437 1.445
2022/20234.399 443 303 175 595 687 658 179 383 578 32 214 152
2023/20242.338 200 274 132 62 204 382 71 462 40 28 34 449
2024/20258.348 230 180 625 210 1.067 876 307 351 1.297 985 1.247 973
2025/202612.693 2.330 980 2.087 3.099 3.895 302 0 0 0 0 0 0
Totale 55.310